🇺🇸 FDA

Intelligence · Patent portfolio

Disc Medicine Patents

Full USPTO pharma patent portfolio for Disc Medicine — grant dates, expiration, and drug cross-links.

Patents
706
Expiring ≤24m
26

Quick answer

Disc Medicine has 706 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 26 expire within 24 months — use filters for patent-cliff planning.

Page 12 of 15

  1. US 8124802

    MAO inhibiting N-benzyl-N-propargyl-amines useful for treating obesity

    Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8088809

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8088926

    Substituted 2-methyl-2-phenoxy-N-propyl-propionamides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity

    Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8088798

    Cannabinoid receptor antagonists/inverse agonists useful for treating obesity

    Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8008038

    Methods for determining oxygen concentration with protoporphyrin IX

    Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7994211

    Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses

    Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7994191

    Heterocyclic cyclopamine analogs and methods of use thereof

    Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7994299

    Compositions and methods for increasing bone mineralization

    Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7985748

    ALPHA2C adrenoreceptor agonists

    Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7977312

    Compositions and methods for increasing bone mineralization

    Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7964646

    3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

    Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7964590

    Cyclopamine lactam analogs and methods of use thereof

    Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7956220

    MAO-B inhibitors useful for treating obesity

    Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7947720

    3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

    Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7927634

    Compositions and methods for treating angiogenesis-related diseases, wounds and cosmetic use of components of Angelica sinensis, and methods of preparation thereof

    Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7928244

    Compounds and methods for inhibiting the interaction of BCL proteins with binding partners

    Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7919583

    Integration-site directed vector systems

    Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7919246

    SEMA4D in cancer diagnosis, detection and treatment

    Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7906491

    Compounds for modulating the activity of exchange proteins directly activated by cAMP (Epacs)

    Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7906482

    Anti-obesity agents

    Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7892730

    Compositions and methods for cancer

    Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7879838

    Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity

    Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7875628

    Cyclopamine analogues and methods of use thereof

    Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7868006

    Heterocyclic substituted piperazines with CXCR3 antagonist activity

    Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7846955

    Salt

    Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7820447

    Compositions and methods for cancer

    Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7816076

    Therapeutic targets in cancer

    Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7802988

    Method for whitening teeth

    Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7799789

    Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity

    Expires Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7786149

    Thiadiazoles as CXC- and CC- chemokine receptor ligands

    Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7758858

    Antibodies associated with alterations in bone density

    Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7759335

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7723340

    Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith

    Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7700274

    Compositions and methods in cancer associated with altered expression of KCNJ9

    Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7687481

    Cannabinoid receptor antagonists/inverse agonists useful for treating obesity

    Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7666889

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7662860

    3D-structure model of SARS coronavirus 3CL protease and anti-SARS drugs

    Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7659269

    Substituted indolealkanoic acids

    Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7655685

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7649115

    MAO-B inhibitors useful for treating obesity

    Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7648994

    Heterocyclic cyclopamine analogs and methods of use thereof

    Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7645441

    Compositions and methods in cancer associated with altered expression of PRLR

    Expires Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7629383

    Double esters

    Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7582312

    Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof

    Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7581864

    Tooth bleaching process

    Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7581846

    Dental light devices having an improved heat sink

    Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7572124

    Apparatus for simultaneous illumination of teeth

    Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7566718

    Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity

    Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Disc Medicine have?

706 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Disc Medicine patents expire?

26 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.